Newsroom
-
August 12 , 2024
Merck to Acquire Investigational B-Cell Depletion Therapy, CN201, from Curon Biopharmaceutical
Read more -
August 1 , 2024
IDEAYA Biosciences Announces Option and License Agreement for Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC Program with Biocytogen
Read more -
July 30 , 2024
Boehringer Ingelheim secures novel immune checkpoint inhibitor with acquisition of Nerio Therapeutics
Read more